As VP of Quality & Regulatory Affair, Dr. Meng ensures compliance with all regulations and laws pertaining to the development and manufacturing of PuraCap products.
Dr. Meng has more than 15 years of pharmaceutical research and development, manufacturing and regulatory experience – including extensive experience formulating and executing regulatory strategies for proprietary and generic drug products and comprehensive knowledge of cGMP/GLP (current Good Manufacturing Practices/Good Labor Practices) compliance and quality systems.
As Director of Chemistry, Manufacturing and Controls (CMC) Management for Hurley Consulting Associates, Ltd., he interfaced with regulatory authorities, including the U.S. FDA (Food and Drug Administration) and EMA (European Medicines Agency), on behalf of clients throughout the drug development process, managed a CMC group, and prepared dossiers for various dosage forms, which resulted in successful submissions of multiple investigational and marketing applications for proprietary and generic drugs domestically and internationally.
As Senior Scientist II in Aerosol R&D for Abbott Laboratories, Inc. (formally Kos Pharmaceuticals, Inc.), Dr. Meng managed and supported projects leading to submissions of an Investigational New Drug for a proprietary and New Drug Application Supplements for a marketed asthma product.
Dr. Meng was also a Research Assistant at the Laboratory for Cancer Research at Rutgers University, where he authored many publications on cancer prevention and co-developed several analytical methods for tea catechins, which have been adopted for laboratories worldwide. He received the Gallo Award from the Cancer Institute of New Jersey in 1999, and the Award for Excellence in Graduate Research in Food Chemistry at the 2002 ACS National Meeting.
Dr. Meng’s academic degrees include: a Master’s in Business Administration from Rutgers University in New Jersey, a PhD in Food Science from Rutgers, and a Master’s degree in Pharmaceutical Science from the Shanghai Institute of the Pharmaceutical Industry, Shanghai, P.R. China.
He is a member of the American Association of Pharmaceutical Scientists (AAPS) and the American Chemical Society (ACS).